• FirefoxInstall the new Firefox »
  •  Dow Down 0.58% Nasdaq Down 0.26%

    OXiGENE, Inc. (OXGN)

    -NasdaqCM
    1.76 Up 0.03(1.73%) Mar 4, 4:00PM EST
    Add to Portfolio
    Prev Close:1.73
    Open:1.73
    Bid:1.67 x 1100
    Ask:2.25 x 9900
    1y Target Est:6.25
    Beta:0.75
    Next Earnings Date:N/A
    Day's Range:1.68 - 1.79
    52wk Range:1.48 - 5.40
    Volume:319,793
    Avg Vol (3m):319,860
    Market Cap:36.44M
    P/E (ttm):N/A
    EPS (ttm):-0.94
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    OXGNUp 1.73%36.44M
    AZNDown 0.72%85.62B
    SNYUp 0.54%127.21B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.80
    Quarterly EPS Est (Dec-14) :-0.17
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    OXiGENE, Inc., a clinical-stage biopharmaceutical company, develops therapeutics primarily to treat cancer. The company focuses on developing vascular disrupting agents (VDAs) that disrupt abnormal blood vessels associated with solid tumor progres... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback